Submission Preparation ChecklistAs part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
- The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
- The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
- Where available, URLs for the references have been provided.
- All co-authors are listed and correct e-mail addresses are provided.
- All co-authors have been notified that the manuscript is being submitted.
- All changes noted in “track revisions” have been accepted.
- Title, including author identifiers, acknowledgments and explanation of any conflicts of interest
- Abstract: Abstract should not exceed 250 words; Reference citations should be avoided; Abbreviations and acronyms, if any, are defined upon first usage; Keywords .
- Graphics and Tables: Figures and tables have captions. Figure insets, if any, are described in the caption; Graphs have clearly labeled axes, legends, and data points;Type fonts are clear and legible.
- The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
- Supplementary files for Publication and supplementary information for Review, if any, are uploaded asseparate files and not placed directly in the manuscript.
The authors who intend to submit their articles are requested to submit their manuscript through the Manuscript Submission Link with a Title Page and Cover Letter.
The manuscript must be as per the Guidelines of the journal, provided on this webpage.
After submission step, the Corresponding Author receives an acknowledgment message with a unique Manuscript No.
Review Policy: The submitted article is initially reviewed by the Editorial Board Member and screened for plagiarism checking. Then sends it to selected referees for specialist review for Peer Review Process. During the review process, the Editorial Board Member or the reviewer may ask the author to make revisions according to the comments made in peer review process. If there vision is not satisfactory it may be sent back to revise again.
Authors make corrections and send a revised version of their manuscript through email with the justification of all changes made.
On the basis of revised manuscript Editor makes the final decision whether the manuscript should be published or not.
The Managing Editor officially informs the main author about the final decision by sending the acceptance e-mail and the invoice bill for article processing charge (APC) Obs: Remember, we don’t charge any article submission charges from the others authors.
The standard peer-review process together with plagiarism checking, language editing and technical handling of the manuscript may take up to 1-2 months and it may take possibly longer if the author is asked to make second or third revisions to the manuscript.
After receiving the payment the manuscript then undergoes language editing, technical editing, proofreading and finally is published.
For further details, please contact the Editor of Global Perspectives on Medical Sciences (GPMS) at firstname.lastname@example.org
ARTICLE PROCESSING CHARGES (APC)
Global Perspectives on Medical Sciences (GPMS) is an open access journal. Open access publishing is a relatively new but encouraging model of publishing articles in scholarly research journals, which provides free and barrier-free access to the full-text of all published articles in a journal Worldwide. It also allows readers/ contributors/ researchers to view, download, print, and redistribute any article without a subscription. It makes thegreater distribution of a contributor’s work than any traditional subscription-based publishing practices. It also increases the impact of any author’s work.
In an open access model, the publication costs of an article are paid from an author or by their affiliating/ supporting institution, in the form of APC. These APC allow publishers to make the full-text of every published article freely available to all. In addition, authors who publish in the open access journals retain the copyright of their work, which is released under a “Creative Commons Attribution License,” enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
Publishing an article in Global Perspectives on Medical Sciences (GPMS) requires APC that will be billed to the submitting/ corresponding author following the acceptance of an article for publication. Apart from these APC, there are no charges involved. The fees to be paid following the acceptance of an article are: £ 230/USD 300/ € 260 per manuscript until 8 pages and will be charged USD 50/ € 45 per extra page. For manuscript with color image will be charged £ 307/USD 400/ € 347.
After accepting the manuscript will be sent to the main author a link of the Paypal system for payment and a Copyright Transfer Form.
Manuscripts should be concise and not be more than 3500 words, with up to five figures or tables. Papers will be returned if they exceed the maximum stated. The word limit refers to the main body of the text and does not include the abstract, references or figure legends.
Collates all empirical evidence that fits pre-specified eligibility criteria to answer a specific research question. It uses explicit, systematic methods that are selected with a view to minimizing bias, thus providing reliable findings from which conclusions can be drawn and decisions made.( http://www.cochrane.org/ or http://www.dcn.ed.ac.uk/camarades/)
The integrative literature review (narrative review, article review) is a distinctive form of research that generates new knowledge about the topic reviewed. It reviews, critiques, and synthesizes representative literature on a topic in an integrated way such that new frameworks and perspectives on the topic are generated. Integrative literature reviews are conducted on dynamic topics that experience rapid growth in the literature and that have not benefited from a comprehensive review and update during an extended period. (Richard J. Torraco, Writing Integrative Literature Reviews, Human Resource Development Review, Vol 15, Issue 4, pp. 404 – 428, 2016)
Case report is a detailed report of the assessment, planning, implementation, evaluation and follow up of an individual patient and contains: 1) unique cases that may represent a previously undescribed condition; 2) unexpected and important association of two or more diseases; 3) any other clinical observation based upon well-documented cases that provides important new information.
Original research findings that do not require a full paper, but are completed studies, may be submitted as Concise Communications. Papers should not exceed 1800 words, and may be accompanied by a maximum of two inserts only (figures/tables). Papers submitted for consideration as Concise Communications should be clearly identified in the author’s cover letter.
Research Letters provide a forum for original research results, excluding case reports, and observations that merit publication and can be reported succinctly. Research letters are reviewed by the Editors or external reviewers. Research letters should include a summary of up to 75 words, not exceed 1000 words (excluding summary) and not have more than one figure or table.
The correspondence section is reserved for letters that are addressing issues or exchanging views on topics arising from published articles in the journal. Correspondence should not exceed 750 words and not have more than one figure or table. These letters are subject to review by the Editors, and may be rejected without written explanation. In some instances, correspondence will be peer-reviewed.
A feature reviews on various topics in biomedical. These articles are invited by the editors. Individuals can write to the editors to ask about an interest in a review. If approved, they will be then officially invited to write one. The instructions are subsequently provided by the Editorial office.
Opinion piece and viewpoint
The Journal will consider articles that review in detail the literature on a topic and give an opinion of an author (s) on that particular area of biomedical. The Opinion pieces should be limited to 2000 words and can have up to two illustrations or tables.
Articles describing experiences with diagnosing and treating diseases will be considered for this section of the journal. These contributors should report personal experiences and give insight into the way culture and medical care within a particular part of the world influences the approaches taken for diseases. The length should be no longer than 1500 words and can have up to two illustrations. Please indicate this section when submitting the manuscript.
POINTS TO CONSIDER BEFORE SUBMISSION
Redundant or duplicate publication
Submissions are accepted on the understanding that they have not been published in their current form or a substantially similar form (in print or electronically, including on a web site), that they have not been accepted for publication elsewhere, and they are not under consideration by another publication. If you are in doubt (particularly in the case of material that you have posted on a web site or an abstract of your work), we ask you to proceed with your submission but to include a copy of the relevant previously published work or work under consideration by other journals.
Conflicts of interest
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, institutional and other relationships that might lead to bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated as none declared. All sources of funding should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading "Conflicts of Interest and Source of Funding:"
Each author must complete and submit the journal's copyright transfer agreement, which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors (www.icmje.org/update.html). The copyright agreement is included in the Author Questionnaire, completed by the submitting author within the Editorial Manager Submission process. Co-authors will automatically receive an Email with a link to the questionnaire upon submission.
Permissions to reproduce previously published material
Authors should include with their submission, copies of written permission to reproduce material published elsewhere (such as illustrations) from the copyright holder. Authors are responsible for paying any fees to reproduce material.
Subject consent forms
Subjects have a right to privacy that should not be infringed without informed consent. Identifying details (written or photographic) should be omitted if they are not essential, but subject data should never be altered or falsified in an attempt to attain anonymity. Complete anonymity is difficult to achieve, and a consent form should be obtained if there is any doubt.
Ethics committee approval
All authors must sign a declaration that the research was conducted within the guidelines below and under the terms of all relevant local legislation. Please also look at the latest version of the Declaration of Helsinki. The Editors reserve the right to judge the appropriateness of the use and treatment of humans or animals in experiments for publication in the journal.
Human experiments: All work must be conducted in accordance with the Declaration of Helsinki. Papers describing experimental work on human participants which carries a risk of harm must include (1) a statement that the experiments were conducted with the understanding and the consent of each participant, and (2) a statement that the responsible ethical committee has approved the experiments.
Animal experiments: In papers describing experiments on living animals, include (1) a full description of any anaesthetic and surgical procedure used, and (2) evidence that all possible steps were taken to avoid animals' suffering at each stage of the experiment. In experiments involving the use of muscle relaxants, describe the precautions taken to ensure adequate anaesthesia.
Experiments on isolated tissues: Indicate precisely how you obtained the donor tissue. The NIH guide for the care and use of laboratory animals (National Institutes of Health Publications No. 80-23, revised 1978) gives guidelines for the acquisition and care of animals.
Clinical trials and behavioural evaluations
Authors reporting results of randomized controlled trials should include with their submission a complete checklist from the CONSORT statement, see http://www.consort-statement.org. For behavioural and public health evaluations involving non-randomized designs, authors should include with their submission a complete checklist from the TREND statement, see http://www.cdc.gov/trendstatement/.
Registration of clinical trials: As a condition for publication of a clinical trial in biomedical, registration of the trial in a public registry is required. Registration of a trial must be at or before the enrolment of participants. We will use the definition adopted by the ICMJE of a clinical trial 'as any research project that prospectively assigns people or a group of people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome'. Studies such as phase 1 trials will be exempt. The editors of GPMS also do not advocate one particular registry but require that the registry utilized meet the criteria set out in the statement of policy of the ICMJE.
Authors are encouraged to follow the Sex and Gender Equity in Research (SAGER) reporting guidelines where relevant. The guidelines, that includes an authors’ checklist for gender-sensitive reporting, are available through the EQUATOR website at http://www.equator-network.org/reporting-guidelines/sager-guidelines/.
All authors must meet the criteria for authorship as established by the International Committee of Medical Journal Editors, that they believe that the paper represents honest work, and that they are able to verify the validity of the results reported.
The corresponding author should list the principal contributions made by each of the authors to the article in the Acknowledgements section of the submission. The journal discourages a long list of authors and does not recommend more than 12, although in principle would consider up to 25 if well-justified. Persons listed as authors should have substantially contributed to the study's conception, design, and performance. An Appendix of additional study sites and participants, in addition to the authors, may be included after the References.
In the case of a large study group involvement, please list the names of authors that meet the ICMJE criteria separately and include a study group name to encompass other contributors. Within the Acknowledgement section list out the names of persons involved in the study group so that they receive individual recognition as contributors.
Please note that copyright disclosure is required for the submission of all manuscripts. This is irrespective of whether an author chooses the Open Access option when an article is accepted for publication.
Authors retain copyright
Authors retain their copyright for all articles they opt to publish open access.
Creative Commons license
All articles published by Academic Journals are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited.
PRESENTATION OF PAPERS
Titles should not contain names of specific studies, a description of the procedures used, or the location of the study unless considered necessary. The given or first name, middle initial and family name (surname) of each author should appear. The family name (surname) must appear in CAPITAL letters. If the work is to be attributed to a department or institution, its full name should be included. Total number of words used should be clearly stated on the Title Page. Any disclaimers should appear on the Title Page, as should the name and address (and email) of the author responsible for correspondence concerning the manuscript and the name and address of the author to whom requests for reprints should be made. Finally, the Title Page should include the sources of any support for the work in the form of grants, equipment, drugs, or any combination of these.
Full papers of an experimental or observational nature may be divided into sections headed Introduction, Methods (including ethical and statistical information), Results, and Discussion (including a conclusion), although reviews may require a different format.
The abstract should not exceed 250 words and should follow one of the following two styles:
Articles concerning original scientific research should include a structured abstract with the following headings and information:
Objective(s): State the primary objective of the paper (if appropriate).
Design: State the principal reasoning for the procedures adopted.
Methods: State the procedures used.
Results: State the main results of the study. Numerical data should be kept to a minimum.
Conclusions: State the conclusions that can be drawn from the data given.
Articles containing original data concerning the course, cause, diagnosis, treatment, prevention or economic analysis of a clinical disorder or an intervention to improve the quality of health care should include a structured abstract with the following headings and information:
Objective: State the main question or objective of the study and the major hypothesis tested, if any.
Study design: Selection and Description of Participants: Describe your selection of the observational or experimental participants (patients or laboratory animals, including controls) clearly, including eligibility and exclusion criteria and a description of the source population. Technical information: Identify the methods, apparatus (give the manufacturer's name and address in parentheses), and procedures in sufficient detail to allow other workers to reproduce the results. Give references to established methods, including statistical methods (see below); provide references and brief descriptions for methods that have been published but are not well known; describe new or substantially modified methods, give reasons for using them, and evaluate their limitations. Identify precisely all drugs and chemicals used, including generic name(s), dose(s), and route(s) of administration.
Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement (http://www.consort-statement.org).
Reporting Guidelines for Specific Study Designs: http://www.equator-network.org/
Statistics: Whenever possible quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Authors should report losses to observation (such as, dropouts from a clinical trial). When data are summarized in the Results section, specify the statistical methods used to analyze them. Avoid non-technical uses of technical terms in statistics, such as 'random' (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample'. Define statistical terms, abbreviations, and most symbols. Specify the computer software used. Use upper italics (P 0.048). For all P values include the exact value and not less than 0.05 or 0.001. Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.
Results: Present your results in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. Do not repeat in the text all the data in the tables or illustrations; emphasize or summarize only important observations. Extra- or supplementary materials and technical detail can be placed in an appendix where it will be accessible but will not interrupt the flow of the text; alternatively, it can be published only in the electronic version of the journal.
When data are summarized in the Results section, give numeric results not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and specify the statistical methods used to analyze them. Restrict tables and figures to those needed to explain the argument of the paper and to assess its support. Use graphs as an alternative to tables with many entries; do not duplicate data in graphs and tables. Where scientifically appropriate, analyses of the data by variables such as age and sex should be included.
Discussion: Include summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); Strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); Interpretation and implications in the context of the totality of evidence (is there a systematic review to refer to, if not, could one be reasonably done here and now?, what this study adds to the available evidence, effects on patient care and health policy, possible mechanisms); Controversies raised by this study; and Future research directions (for this particular research collaboration, underlying mechanisms, clinical research).
Do not repeat in detail data or other material given in the Introduction or the Results section. In particular, contributors should avoid making statements on economic benefits and costs unless their manuscript includes economic data and analyses. Avoid claiming priority and alluding to work that has not been completed. New hypotheses may be stated if needed, however they should be clearly labeled as such. About 30 references can be included. These articles generally should not have more than six authors.
The abstract should be followed by a list of 4-7 keywords or short phrases which will assist the cross-indexing of the article and which may be published. The terms used should be from the Medical Subject Headings list of the US National Library of Medicine (http://www.nlm.nih.gov/mesh/meshhome.html).
The corresponding author should list the principal contributions made by each of the authors to the article. Acknowledgements should be made only to those who have made a substantial contribution to the study. Authors are responsible for obtaining written permission from people acknowledged by name in case readers infer their endorsement of data and conclusions. Sources of funding should be placed in this section.
Indicating the relevant reference in the text:
A number enclosed in square brackets, eg. or , placed in the text of the essay, indicates the relevant reference.
Each reference number should be enclosed in square brackets on the same line as the text, before any punctuation, with a space before the bracket.
Citations are numbered in the order in which they appear in the text and each citation corresponds to a numbered reference containing publication information about the source cited in the reference list at the end of the publication, essay or assignment.
Once a source has been cited, the same number is used in all subsequent references. No distinction is made between print and electronic references when citing within the text.
Here are some examples of this kind of referencing:
"...end of the line for my research ."
"The theory was first put forward in 1987 ." "Scholtz  has argued that......."
"Several recent studies [3, 4, 15, 16] have suggested that..."
"For example, see ."
It is not necessary to mention either the author(s) or the the date of the reference unless it is relevant to your text.
It is not necessary to say " in reference  ..." "In  ..." is sufficient.
Citing more than one reference at a time
When citing more than one source at a time, the preferred method is to list each reference number separately with a comma or dash between each reference:nAcceptable [1, 3, 5] e [1-5].
Citing a reference multiple times
When citing a source for a second or subsequent time, do not use ibid or op. cit.
In the text, repeat the earlier reference number.
If referring to a different page number, or other reference, within the source, use the following forms:
[3, pp. 5-10], [3, Ch. 2, pp. 6-21], [3, Fig. 1], [3, Sec. 4.5]
References should therefore be listed as follows:
- Arrami M, Garner H. A tale of two citations. Nature. 2008;451(7177): 397–399
- Ramalho R, Helffrich G, Schmidt DN, Vance D. Tracers of uplift and subsidence in the Cape Verde archipelago. Journal of the Geological Society. 2010;167(3): 519–538.
- Wang F, Maidment G, Missenden J, Tozer R. The novel use of phase change materials in refrigeration plant. Part 1: Experimental investigation. Applied Thermal Engineering. 2007;27(17–18): 2893–2901.
Personal communication (J.Smith, personal communication) should be authorized by those involved, in writing, and unpublished data should be cited as (unpublished data). Both should be used as sparingly as possible and only when the unpublished data referred to is peripheral rather than central to the discussion. References to manuscripts in preparation or submitted, but not yet accepted, should be cited in the text as (B.Smith and N.Jones, in preparation) and should NOT be included in the list of references.
- Watkins PJ. ABC of Diabetes. 5th ed. London: Blackwell Publishing; 2003.
- Simons NE, Menzies B, Matthews M. A Short Course in Soil and Rock Slope Engineering. London: Thomas Telford Publishing; 2001.
Personal communications and unpublished work should not feature in the reference list but should appear in parentheses in the text. Unpublished work accepted for publication but not yet released should be included in the reference list with the words ‘in press’ in parentheses beside the name of the journal concerned. References must be verified by the author(s) against the original documents.
References should conform to the “Citing & Referencing: Vancouver Style”, available at https://www.imperial.ac.uk/media/imperial-college/administration-and-support-services/library/public/vancouver.pdf
Each table should be typed on a separate sheet in double spacing. Tables should not be submitted as photographs. Each table should be assigned an Arabic numeral, e.g. (Table 3) and a brief title. Vertical rules should not be used. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations that are used in each table. Identify statistical measures of variations, such as standard deviation and standard error of the mean.
Be sure that each table is cited in the text. If you use a table or data from another published or unpublished source, obtain permission and acknowledge the source fully.
All tables must be inserted in doc or docx format.
References to figures and tables should be made in order of appearance in the text and should be in Arabic numerals in parentheses, e.g. (Fig. 2). If hard copies of figures are submitted they should have a label pasted to the back bearing the figure number, the title of the paper, the author's name and a mark indicating the top of the figure. Illustrations should not be mounted. Half-tone illustrations should be presented as glossy prints to a width of 82 mm; line illustrations should be presented as original artwork or prints to a width of 82 mm or, when the illustration demands it, to a width of 173 mm. Photomicrographs must have internal scale markers. If photographs of people are used, their identities must be obscured or the picture must be accompanied by written consent to use the photograph. If a figure has been published before, the original source must be acknowledged and written permission from the copyright holder for both print and electronic formats should be submitted with the material. Permission is required regardless of authorship or publisher, except for documents in the public domain. Figures may be reduced, cropped or deleted at the discretion of the editor. Colour illustrations are acceptable but authors will be expected to cover the extra reproduction costs (for current charges, contact the publisher).
All illustrations must be inserted in doc or docx format.
Legends for illustrations
Captions should be typed in double spacing, beginning on a separate sheet of paper. Each one should have an Arabic numeral corresponding to the illustration to which it refers. Internal scales should be explained and staining methods for photomicrographs should be identified.
Units of measurement
Measurements of length, height, weight, and volume should be reported in metric units (metre, kilogram, or litre) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimetres of mercury.
All haematologic and clinical chemistry measurements should be reported in the metric system in terms of the International System of Units (SI). Editors may request that alternative or non-SI units be added by the authors before publication.
Abbreviations and symbols
Use only standard abbreviations. Avoid abbreviations in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Offprints may be purchased using the appropriate form that will be made available with proofs. Orders should be sent when the proofs are returned; orders received after this time cannot be fulfilled.